Skip to Main Content Skip to Main Content

HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: Big 4 Journals

Big 4 Journals current awareness bulletin

Frequency: Weekly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To receive email notifications about new issues of this bulletin, please email:

This bulletin is based on the equivalent bulletin produced by Bodleian Health Care Libraries:

17th June 2024

The BMJ 17th-23rd Jun 2024

Diagnosis and management of resistant hypertension 10.1136/bmj-2023-079108

Lateral episiotomy or no episiotomy in vacuum assisted delivery in nulliparous women (EVA) 10.1136/bmj-2023-079014

Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma 10.1136/bmj-2023-077890

Recognition, diagnosis, and early management of suspected sepsis: summary of updated NICE guidance 10.1136/bmj.q1173

JAMA 18th June 2024, 331(23)

Krill oil for knee osteoarthritis 10.1001/jama.2024.6063

Stewardship prompts to improve antibiotic selection for: pneumonia 10.1001/jama.2024.6248; urinary tract infection 10.1001/jama.2024.6259

The Lancet 22nd-28th June 2024, 403(10445)

Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment 10.1016/S0140-6736(24)00425-2

Health-care workforce implications of the Dobbs v Jackson Women's Health Organization decision 10.1016/S0140-6736(24)00581-6

See also: Societal implications of the Dobbs v Jackson Women's Health Organization decision 10.1016/S0140-6736(24)00534-8

Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM) 10.1016/S0140-6736(24)00594-4

LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis 10.1016/S0140-6736(24)00821-3

Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION) 10.1016/S0140-6736(24)00885-7

New England Journal of Medicine 20th June 2024, 390(23)

APOE3 Christchurch heterozygosity and autosomal dominant Alzheimer’s disease 10.1056/NEJMoa2308583

Combination targeted therapy in relapsed diffuse large B-cell lymphoma 10.1056/NEJMoa2401532

Congenital and acquired Chiari syndrome 10.1056/NEJMra2308055

Engineering an insulin complex to treat diabetes 10.1056/NEJMcibr2400047

Noninvasive ventilation for preoxygenation during emergency intubation 10.1056/NEJMoa2313680

A novel anti-CD38 monoclonal antibody for treating immune thrombocytopenia 10.1056/NEJMoa2400409

10th June 2024

The BMJ 10th-16th Jun 2024

Antiplatelet therapy after coronary artery bypass surgery 10.1136/bmj-2023-075707

Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019 10.1136/bmj-2023-078432

How an opioid giant deployed a playbook for moulding doctors’ minds 10.1136/bmj.q1208

Pigmented skin lesions (practice review)

Vitamin B12 deficiency: NICE guideline summary 10.1136/bmj.q1019

Wider use of tranexamic acid to reduce surgical bleeding could benefit patients and health systems 10.1136/bmj-2024-079444

JAMA 11th June 2024, 331(22)

Cancer stage compared with mortality as end points in randomized clinical trials of cancer screening: a systematic review and meta-analysis 10.1001/jama.2024.5814

Prognostic value of cardiovascular biomarkers in the population 10.1001/jama.2024.5596  

The Lancet 15th-21st June 2024, 403(10444)

Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 10.1016/S0140-6736(24)00700-1

Hypopituitarism (review) 10.1016/S0140-6736(24)00342-8

Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease (ORFAN) 10.1016/S0140-6736(24)00596-8

Persistent physical symptoms: definition, genesis and management 10.1016/S0140-6736(24)00623-8

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2) 10.1016/S0140-6736(24)00921-8

New England Journal of Medicine 13th June 2024, 390(22)

Early diagnosis and treatment of COPD and asthma 10.1056/NEJMoa2401389

Implications of race adjustment in lung-function equations 10.1056/NEJMsa2311809

Indolent CD4+ CAR T-cell lymphoma after cilta-cel CAR T-cell therapy 10.1056/NEJMoa2401530

Nutrition in medicine: diets 10.1056/NEJMra2211889

Risk of second tumors and T-cell lymphoma after CAR r-cell therapy.1056/NEJMoa2401361

3rd June 2024

The BMJ 3rd-9th Jun 2024

Advances in diagnosis and management of cancer of the esophagus 10.1136/bmj-2023-074962  

Mailed feedback to primary care physicians on antibiotic prescribing for patients aged 65 years and older 10.1136/bmj-2024-079329

Why digital innovation may not reduce healthcare’s environmental footprint 10.1136/bmj-2023-078303

JAMA 4th June 2024, 331(21)

Bird flu outbreak in dairy cows is widespread, raising public health concerns 10.1001/jama.2024.8886

Cardiovascular burden of the V142I transthyretin variant 10.1001/jama.2024.4467

Causal inference about the effects of interventions from observational studies in medical journals 10.1001/jama.2024.7741

Non–high-density lipoprotein cholesterol levels from childhood to adulthood and cardiovascular disease events 10.1001/jama.2024.4819

Ponatinib vs imatinib in frontline Philadelphia chromosome–positive acute lymphoblastic leukemia 10.1001/jama.2024.4783

The Lancet 8th-14th June 2024, 403(10443)

Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: (BAMBINI)  10.1016/S0140-6736(24)00538-5

Effectiveness of kangaroo mother care before clinical stabilisation versus standard care among neonates at five hospitals in Uganda (OMWaNA) 10.1016/S0140-6736(24)00064-3

Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach 10.1016/S0140-6736(24)01019-5

Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance 10.1016/S0140-6736(24)00878-X

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II) 10.1016/S0140-6736(24)00101-6

New England Journal of Medicine 6th June 2024, 390(21)

Gene editing for CEP290-associated retinal degeneration 10.1056/NEJMoa2309915

Genome sequencing for diagnosing rare diseases 10.1056/NEJMoa2314761

Magnesium disorders (review) 10.1056/NEJMra1510603

Neoadjuvant immunotherapy in locally advanced mismatch repair–deficient colon cancer 10.1056/NEJMoa2400634

Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus 10.1056/NEJMoa2312573